NEW YORK (GenomeWeb News) – Genomics scientists at the Broad Institute of Harvard and MIT will use a $3 million foundation grant to conduct integrative research with chemical biologists focused on type 1 diabetes.
The Broad Institute’s scientists will use the grant from the Juvenile Diabetes Research Foundation to try to find “ways to encourage the human body to replenish the cells that are missing in type 1 diabetes.”
MIT’s researchers will try to find out if it is possible to regenerate cells that are lost or damaged by disease.
While the focus of this research is the genomics and chemistry involved in type 1 diabetes, chemical biology researcher Stuart Schreiber also said the “approach holds promise for practically any disease involving a cellular deficiency.”
As an example, the Broad Institute said, if the cells that help the pancreas create insulin could be induced to multiply enough to restore the insulin, they could serve as a treatment for type 1 diabetes. The two-year grant will focus on that effort, and future research will involve using small molecules to influence cells and cell behavior.